poly-MVA

Myelodysplasia: Potential Therapies

Dr. Paul S. Anderson Based on known data regarding MDS and its etiology as well as potential therapies (see below) there is a low probability of ‘cure’ using known therapies.  Supportive care is the mainstay of therapy especially in patients over 60 years of age. Oxidative treatments are indicated, as well as transplantation, growth factors, …

Myelodysplasia: Potential Therapies Read More »

Townsend Letter Article on Metabolic Cancer Therapy

This appeared originally in the August-September issue of the Townsend Letter, 2018 It outlines the evolution of, a case series using and the actual protocols we now employ in our integrative metabolic cancer therapy.

THERAPEUTIC OPTIONS FOR PROGRESSING PARKINSON’S CONT

QUESTION: 60 yo male – Medical history: Parkinson’s plus syndrome (suspicion for PSP type), type II diabetes, HTN. Current Rx metformin, Invokana, Monopril, Sinemet, LDN Current symptoms include bradykinesia, ataxia, dysarthria, widened gait that is unbalanced, cognitive impairment (subjective and observed complaints of recall and confusion) however MOCA score continues to be WNL. He is no longer …

THERAPEUTIC OPTIONS FOR PROGRESSING PARKINSON’S CONT Read More »

FLUOROQUINOLONE TOXICITY CONT

QUESTION: I have a patient with fluoroquinolone toxicity. She was referred to me by a chiropractic neurologist for glutathione infusions. She has not responded particularly well to that approach, so if you could please share your perspective, I would again be most appreciative. She is also finding mixed info about whether or not the Cipro remains in …

FLUOROQUINOLONE TOXICITY CONT Read More »

Scroll to Top